280 related articles for article (PubMed ID: 22458680)
1. Analysis of structure-based virtual screening studies and characterization of identified active compounds.
Ripphausen P; Stumpfe D; Bajorath J
Future Med Chem; 2012 Apr; 4(5):603-13. PubMed ID: 22458680
[TBL] [Abstract][Full Text] [Related]
2. Virtual compound screening in drug discovery.
Stumpfe D; Ripphausen P; Bajorath J
Future Med Chem; 2012 Apr; 4(5):593-602. PubMed ID: 22458679
[TBL] [Abstract][Full Text] [Related]
3. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems.
Kellenberger E; Foata N; Rognan D
J Chem Inf Model; 2008 May; 48(5):1014-25. PubMed ID: 18412328
[TBL] [Abstract][Full Text] [Related]
4. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
Evers A; Hessler G; Matter H; Klabunde T
J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
[TBL] [Abstract][Full Text] [Related]
5. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
6. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
Mahasenan KV; Li C
J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
[TBL] [Abstract][Full Text] [Related]
7. Efficient virtual screening using multiple protein conformations described as negative images of the ligand-binding site.
Virtanen SI; Pentikäinen OT
J Chem Inf Model; 2010 Jun; 50(6):1005-11. PubMed ID: 20504004
[TBL] [Abstract][Full Text] [Related]
8. Considerations in compound database preparation--"hidden" impact on virtual screening results.
Knox AJ; Meegan MJ; Carta G; Lloyd DG
J Chem Inf Model; 2005; 45(6):1908-19. PubMed ID: 16309298
[TBL] [Abstract][Full Text] [Related]
9. Virtual high-throughput screening of molecular databases.
Seifert MH; Kraus J; Kramer B
Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
[TBL] [Abstract][Full Text] [Related]
10. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening.
Nagarajan S; Doddareddy Mr; Choo H; Cho YS; Oh KS; Lee BH; Pae AN
Bioorg Med Chem; 2009 Apr; 17(7):2759-66. PubMed ID: 19285872
[TBL] [Abstract][Full Text] [Related]
11. Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening.
Rastelli G; Degliesposti G; Del Rio A; Sgobba M
Chem Biol Drug Des; 2009 Mar; 73(3):283-6. PubMed ID: 19207463
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin.
Jenkins JL; Kao RY; Shapiro R
Proteins; 2003 Jan; 50(1):81-93. PubMed ID: 12471601
[TBL] [Abstract][Full Text] [Related]
13. Lead finder: an approach to improve accuracy of protein-ligand docking, binding energy estimation, and virtual screening.
Stroganov OV; Novikov FN; Stroylov VS; Kulkov V; Chilov GG
J Chem Inf Model; 2008 Dec; 48(12):2371-85. PubMed ID: 19007114
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening strategies in drug discovery.
McInnes C
Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
[TBL] [Abstract][Full Text] [Related]
15. Normalizing molecular docking rankings using virtually generated decoys.
Wallach I; Jaitly N; Nguyen K; Schapira M; Lilien R
J Chem Inf Model; 2011 Aug; 51(8):1817-30. PubMed ID: 21699246
[TBL] [Abstract][Full Text] [Related]
16. Investigation of MM-PBSA rescoring of docking poses.
Thompson DC; Humblet C; Joseph-McCarthy D
J Chem Inf Model; 2008 May; 48(5):1081-91. PubMed ID: 18465849
[TBL] [Abstract][Full Text] [Related]
17. Towards improving compound selection in structure-based virtual screening.
Waszkowycz B
Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
[TBL] [Abstract][Full Text] [Related]
18. Discovery of small molecule inhibitors of integrin alphavbeta3 through structure-based virtual screening.
Zhou Y; Peng H; Ji Q; Qi J; Zhu Z; Yang C
Bioorg Med Chem Lett; 2006 Nov; 16(22):5878-82. PubMed ID: 16982193
[TBL] [Abstract][Full Text] [Related]
19. Enrichment of virtual hits by progressive shape-matching and docking.
Choi J; He N; Kim N; Yoon S
J Mol Graph Model; 2012 Feb; 32():82-8. PubMed ID: 22088763
[TBL] [Abstract][Full Text] [Related]
20. Towards structure-based protein drug design.
Zhang C; Lai L
Biochem Soc Trans; 2011 Oct; 39(5):1382-6, suppl 1 p following 1386. PubMed ID: 21936819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
